Targeting immunoliposomes to EGFR-positive glioblastoma

BACKGROUND: We assessed the capacity of epidermal growth factor receptor (EGFR)-targeted immunoliposomes to deliver cargo to brain tumor tissue in patients with relapsed glioblastoma harboring an EGFR amplification. We aimed to assess the tolerability and effectiveness of anti-EGFR immunoliposomes l...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasenda, B., König, D., Manni, M., Ritschard, R., Duthaler, U., Bartoszek, E., Bärenwaldt, A., Deuster, S., Hutter, G., Cordier, D., Mariani, L., Hench, J., Frank, S., Krähenbühl, S., Zippelius, A., Rochlitz, C., Mamot, C., Wicki, A., Läubli, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741448/
https://www.ncbi.nlm.nih.gov/pubmed/34998092
http://dx.doi.org/10.1016/j.esmoop.2021.100365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741448/
https://www.ncbi.nlm.nih.gov/pubmed/34998092
http://dx.doi.org/10.1016/j.esmoop.2021.100365

Ejemplares similares